Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
HER2+ Breast & Stomach Cancer Treatment Option | Herceptin® (trastuzumab)
Find information about Herceptin® (trastuzumab), a treatment for HER2+ early and metastatic breast cancer and stomach cancer/GEJ. See full safety & Boxed Warnings for more information.
This website is hosted with Genentech, Inc., which reserves the following IP addresses for metastaticgastriccancertherapy.com: 72.34.128.114. Moreover, DNS used with this website include a1-178.akam.net, a18-66.akam.net, a4-67.akam.net, a6-65.akam.net, a7-66.akam.net, a9-66.akam.net. Subnet identifier ranges from 72.34.128.0 to 72.34.159.255. Classless Inter-Domain Routing (CIDR) is 72.34.128.0/19. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
a1-178.akam.net
a18-66.akam.net
a4-67.akam.net
a6-65.akam.net
a7-66.akam.net
a9-66.akam.net
{{value}}
2010-10-25
2023-10-25
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of metastaticgastriccancertherapy.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2023-10-25. According to open source data, you can reach the owner at domain-management-d@gene.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
543.3K
N/A
N/A
534
N/A
N/A
N/A
N/A
N/A
N/A